Prognostic and predictive value of nuclear imaging in endocrine oncology.

Adrenal Gland Neoplasms Humans Neuroendocrine Tumors / diagnostic imaging Prognosis Radionuclide Imaging Thyroid Neoplasms / diagnostic imaging
Endocrinology Neuroendocrine Nuclear medicine PET Predictive Prognostic

Journal

Endocrine
ISSN: 1559-0100
Titre abrégé: Endocrine
Pays: United States
ID NLM: 9434444

Informations de publication

Date de publication:
01 2020
Historique:
received: 25 07 2019
accepted: 02 11 2019
pubmed: 18 11 2019
medline: 22 6 2021
entrez: 18 11 2019
Statut: ppublish

Résumé

In the last few years, the role and use of medical technologies in (neuro)endocrine oncology has greatly evolved allowing not only important diagnostic information but also prognostic stratification in different clinical situations. The terms "prognostic" and "predictive" are commonly used to describe the relationships between biomarkers and patients' clinical outcomes but have quite different meaning. The present work discusses the prognostic and predictive value of nuclear medicine imaging. It critically reviews the clinical significance and potential impact of molecular examinations on follow-up and therapeutic strategies in patients with neuroendocrine neoplasms, thyroid tumors, and adrenal malignancies.

Identifiants

DOI: 10.1007/s12020-019-02131-4 PMID: 31734779 PMC: PMC7441826
pubmed: 31734779
doi: 10.1007/s12020-019-02131-4
pii: 10.1007/s12020-019-02131-4
pmc: PMC7441826
mid: NIHMS1619683
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

9-19

Subventions

Organisme : Intramural NIH HHS
ID : Z99 HD999999
Pays : United States

Références

PLoS Med. 2013;10(2):e1001380
pubmed: 23393429
JAMA Oncol. 2017 Oct 1;3(10):1335-1342
pubmed: 28448665
Clin Cancer Res. 2017 Aug 15;23(16):4617-4624
pubmed: 28428192
Minerva Endocrinol. 2018 Sep;43(3):341-355
pubmed: 28949122
Int J Cancer. 2012 Jul 15;131(2):438-45
pubmed: 21898389
World J Surg. 2013 Jan;37(1):107-12
pubmed: 23001287
J Nucl Med. 2014 Aug;55(8):1260-6
pubmed: 24876204
J Nucl Med. 2016 Dec;57(12):1851-1857
pubmed: 27469355
Mol Oncol. 2008 Apr;1(4):406-12
pubmed: 19383314
J Nucl Med. 2018 Jul;59(7):1085-1091
pubmed: 29572257
J Clin Oncol. 2009 Oct 1;27(28):4656-63
pubmed: 19704057
Neuroendocrinology. 2014;99(2):63-74
pubmed: 24458014
Eur J Nucl Med Mol Imaging. 2013 Jun;40(6):881-8
pubmed: 23443937
Oncologist. 2018 Feb;23(2):186-192
pubmed: 29118267
Endocrine. 2012 Dec;42(3):535-45
pubmed: 22527889
J Nucl Med. 2014 Nov;55(11):1786-90
pubmed: 25286923
Acad Radiol. 2012 Oct;19(10):1290-9
pubmed: 22819076
J Clin Endocrinol Metab. 2006 Feb;91(2):498-505
pubmed: 16303836
Clin Nucl Med. 2012 Jun;37(6):e141-7
pubmed: 22614212
Int J Endocrinol. 2013;2013:856189
pubmed: 23653645
Ann Oncol. 2013 Jan;24(1):152-60
pubmed: 22967994
Eur J Nucl Med Mol Imaging. 2017 Mar;44(3):490-499
pubmed: 27704193
Endocrinol Metab Clin North Am. 2019 Mar;48(1):181-197
pubmed: 30717901
Mol Imaging Biol. 2003 Jan-Feb;5(1):42-8
pubmed: 14499161
BMJ. 2009 Feb 23;338:b375
pubmed: 19237405
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1482-91
pubmed: 24781870
Eur J Nucl Med Mol Imaging. 2014 Aug;41(8):1501-10
pubmed: 24806110
Cancer Treat Rev. 2018 Nov;70:209-222
pubmed: 30292979
Eur J Nucl Med Mol Imaging. 2019 Sep;46(10):2112-2137
pubmed: 31254038
Mol Imaging Biol. 2015 Jun;17(3):313-8
pubmed: 25319765
Sci Rep. 2019 Mar 13;9(1):4339
pubmed: 30867449
J Nucl Med. 2016 Sep;57(9):1339-42
pubmed: 27151981
Nuklearmedizin. 2007;46(4):121-8
pubmed: 17690789
J Clin Endocrinol Metab. 2017 Jul 1;102(7):2465-2472
pubmed: 28431167
Endocrinol Metab Clin North Am. 2018 Sep;47(3):505-523
pubmed: 30098713
Diagn Interv Imaging. 2014 Mar;95(3):289-300
pubmed: 24034971
Contrast Media Mol Imaging. 2018 Feb 26;2018:2340389
pubmed: 29681780
Curr Opin Oncol. 2017 Jan;29(1):1-6
pubmed: 27906859
Thyroid. 2014 Sep;24(9):1394-9
pubmed: 24820222
Theranostics. 2017 Mar 1;7(5):1159-1163
pubmed: 28435455
Endocrine. 2019 Feb;63(2):293-300
pubmed: 30206772
J Nucl Med. 2017 Sep;58(Suppl 2):3S-9S
pubmed: 28864612
Cancer Imaging. 2012 May 21;12:173-84
pubmed: 22743056
Ann Endocrinol (Paris). 2017 Feb;78(1):38-42
pubmed: 27989550
Trends Endocrinol Metab. 2017 Nov;28(11):807-817
pubmed: 28867159
Isr Med Assoc J. 2017 Feb;19(2):114-118
pubmed: 28457063
Clin Cancer Res. 2010 Feb 1;16(3):978-85
pubmed: 20103666
J Clin Endocrinol Metab. 2009 Apr;94(4):1310-6
pubmed: 19158200
Eur J Nucl Med Mol Imaging. 2020 Jan;47(1):61-77
pubmed: 31482429
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S714-20
pubmed: 26282908
Eur J Nucl Med Mol Imaging. 2011 May;38 Suppl 1:S48-56
pubmed: 21484380
J Thorac Oncol. 2006 Oct;1(8):837-46
pubmed: 17409968
J Clin Endocrinol Metab. 2011 Mar;96(3):665-71
pubmed: 21193541
N Engl J Med. 2017 Jan 12;376(2):125-135
pubmed: 28076709
Clin Nucl Med. 2015 Jun;40(6):e334-5
pubmed: 25706791
Medicine (Baltimore). 2015 Dec;94(48):e2063
pubmed: 26632889
J Nucl Med. 2018 May;59(5):756-761
pubmed: 29025983
J Nucl Med. 2016 Dec;57(12):1949-1956
pubmed: 27811124
Clin Nucl Med. 2018 Sep;43(9):641-647
pubmed: 30015659
Q J Nucl Med Mol Imaging. 2011 Feb;55(1):57-65
pubmed: 21285923
N Engl J Med. 2014 Jul 17;371(3):224-33
pubmed: 25014687
Pancreas. 2016 Nov;45(10):1386-1393
pubmed: 27622342
Endocr Relat Cancer. 2017 Jun;24(6):R203-R221
pubmed: 28400403
Endocr Pract. 2017 Aug;23(8):942-948
pubmed: 28614009
Theranostics. 2017 Mar 1;7(5):1149-1158
pubmed: 28435454
J Clin Endocrinol Metab. 2006 Mar;91(3):920-5
pubmed: 16368753
Future Oncol. 2018 Jan;14(2):111-122
pubmed: 29072093
Thyroid. 2016 Jan;26(1):1-133
pubmed: 26462967
J Med Imaging Radiat Oncol. 2015 Jun;59(3):278-80
pubmed: 26053477
Endocr Relat Cancer. 2011 Jan 13;18(1):159-69
pubmed: 21118976
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2367-2374
pubmed: 30715419
Ann Endocrinol (Paris). 2017 Jul;78(3):162-175
pubmed: 28578852
Ann Nucl Med. 2018 Jan;32(1):7-15
pubmed: 28986764
Endocr Relat Cancer. 2019 May;26(5):539-550
pubmed: 30893643

Auteurs

Giorgio Treglia (G)

Clinic of Nuclear Medicine and PET/CT Center, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.
Health Technology Assessment Unit, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Clinical Trial Unit, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Department of Nuclear Medicine and Molecular Imaging, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.

Bernard Goichot (B)

Endocrinology and Internal Medicine Department, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg, France.

Luca Giovanella (L)

Clinic of Nuclear Medicine and PET/CT Center, Imaging Institute of Southern Switzerland, Bellinzona, Switzerland.
University Hospital and University of Zürich, Zürich, Switzerland.

Elif Hindié (E)

Nuclear Medicine Department, Haut-Lévêque Hospital, University Hospitals of Bordeaux, University of Bordeaux, Bordeaux, France.
LabEx TRAIL, University of Bordeaux, Bordeaux, France.

Abhishek Jha (A)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

Karel Pacak (K)

Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA.

David Taïeb (D)

Nuclear Medicine, La Timone University Hospital, Aix-Marseille University, Marseille, France.
European Center for Research in Medical Imaging, Aix-Marseille University, Marseille, France.

Thomas Walter (T)

Medical Oncology, Edouard Herriot Hospital, Hospices Civils de Lyon, Lyon, France.
University of Lyon, Université Lyon 1, Lyon, France.

Alessio Imperiale (A)

Biophysics and Nuclear Medicine, Hautepierre Hospital, University Hospitals of Strasbourg, Strasbourg University/FMTS, Strasbourg, France. alessio.imperiale@chru-strasbourg.fr.
Molecular Imaging-DRHIM, IPHC, UMR 7178, CNRS/Unistra, Strasbourg, France. alessio.imperiale@chru-strasbourg.fr.
ORCID: 0000-0003-2751-5146

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies endocriniennes › Tumeurs des glandes endocrines › Tumeurs de la surrénale › Prognostic and predictive value of nuclear...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Prognostic and predictive value of nuclear...
questionsmedicales.fr › Tumeurs › Tumeurs par type histologique › Tumeurs du tissu nerveux › Tumeurs neuroectodermiques › Tumeurs neuroendocrines › Prognostic and predictive value of nuclear...
questionsmedicales.fr › Diagnostic › Pronostic › Prognostic and predictive value of nuclear...
questionsmedicales.fr › Diagnostic › Techniques et procédures diagnostiques › Techniques de diagnostic radioisotopique › Scintigraphie › Prognostic and predictive value of nuclear...
questionsmedicales.fr › Maladies endocriniennes › Maladies de la thyroïde › Tumeurs de la thyroïde › Prognostic and predictive value of nuclear...